End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
15.08 CNY | +2.65% | +2.17% | -0.40% |
Apr. 17 | Aodong Medicine's 2023 Profit Declines 18%; Revenue Up 20% | MT |
Apr. 16 | Jilin Aodong Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Sales 2024 * | 4.12B 569M | Sales 2025 * | 4.83B 667M | Capitalization | 18.03B 2.49B |
---|---|---|---|---|---|
Net income 2024 * | 2.33B 321M | Net income 2025 * | 2.69B 372M | EV / Sales 2024 * | 4.38 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 3.73 x |
P/E ratio 2024 * |
7.52
x | P/E ratio 2025 * |
6.51
x | Employees | 5,646 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 69.05% |
1 day | +2.65% | ||
1 week | +2.17% | ||
Current month | +4.29% | ||
1 month | +5.01% | ||
3 months | +2.10% | ||
6 months | -8.55% | ||
Current year | -0.40% |
Managers | Title | Age | Since |
---|---|---|---|
Shu Qin Guo
CEO | Chief Executive Officer | 61 | 97-12-31 |
Kai Yang
DFI | Director of Finance/CFO | 47 | 04-04-30 |
Da Long Zhao
DFI | Director of Finance/CFO | 50 | 99-06-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Xiu Lin Li
CHM | Chairman | 71 | 93-01-31 |
Shu Qin Guo
CEO | Chief Executive Officer | 61 | 97-12-31 |
Yong Feng Chen
CHM | Chairman | 57 | 00-09-30 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 15.08 | +2.65% | 23,697,950 |
24-04-25 | 14.69 | -0.61% | 8,121,685 |
24-04-24 | 14.78 | +0.14% | 8,104,715 |
24-04-23 | 14.76 | +0.48% | 9,348,471 |
24-04-22 | 14.69 | -0.47% | 9,672,024 |
End-of-day quote Shenzhen S.E., April 25, 2024
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-0.40% | 2.49B | |
+25.83% | 661B | |
+27.00% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+13.09% | 231B | |
+5.46% | 200B | |
-9.61% | 195B | |
-6.26% | 145B |
- Stock Market
- Equities
- 000623 Stock